Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Frank J. Sasinowski
Observed names:
F J Sasinowski,
Frank J Sasinowski
Observed institutions:
University of Rochester Medicine,
National Organization for Rare Disorders,
University of Rochester
OpenAlex ID:
A5014472965
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
2012
·
Frank J. Sasinowski
·
Drug Information Journal
·
54
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs: Update, July 2010 to June 2014
2015
·
Frank J. Sasinowski
, Erika B. Panico
, et al.
·
Therapeutic Innovation & Regulatory Science
·
43
Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
1998
·
J E Beach
, G A Faich
, et al.
·
PubMed
·
39
Review of methods for estimating the prevalence of rare diseases
2024
·
Nisha Venugopal
, Gitismita Naik
, et al.
·
Rare Disease and Orphan Drugs Journal
·
11
PDF
FDA's Flexibility in Subpart H Approvals: Assessing Quantum of Effectiveness Evidence.
2016
·
Frank J Sasinowski
, Alexander J Varond
·
PubMed
·
6
Single-Study Approvals: Quantum of Evidence Required
2019
·
Frank J. Sasinowski
, Michelle L. Butler
·
Therapeutic Innovation & Regulatory Science
·
4
PDF
Orphan Drugs and Rare Diseases
2022
·
James E. Valentine
, Frank J. Sasinowski
·
Springer eBooks
·
3
Orphan Drugs and Rare Diseases
2020
·
James E Valentine
, Frank J Sasinowski
·
Springer eBooks
Show more works
View as search
Works count:
8
Citation count:
160
H-index:
5
I10-index:
4
Year
Topic
Type
